Ekonomik Sonuçlar

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (yeni pencere açar)

Kaserer A, Rössler J, Braun J, Farokhzad F, Pape HC, Dutkowski P, Plass A, Horisberger T, Volbracht J, Manz MG, Spahn DR

Kaynak‎: Anaesthesia 2019;74(12):1534-41.

İndeks‎: PubMed 31448406

DOI‎: 10.1111/anae.14816

https://www.ncbi.nlm.nih.gov/pubmed/31448406 (yeni pencere açar)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (yeni pencere açar)

Kaur MN, Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Carruthers J, Li N, Liu Y, Xie F

Kaynak‎: Blood Adv. 2022;6(3):785-92.

İndeks‎: PubMed 34781363

DOI‎: 10.1182/bloodadvances.2021005627

https://pubmed.ncbi.nlm.nih.gov/34781363/ (yeni pencere açar)

HEMATOLOJI

Ekonomik Sonuçlar

Türkçe

Ekonomik Sonuçlar

https://assetsnffrgf-a.akamaihd.net/assets/ct/1add6d1d93/images/syn_placeholder_sqr.png

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (yeni pencere açar)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (yeni pencere açar)

Hastane İrtibat Heyeti Yerel Temsilcisiyle İletişime Geçin

Tıbbi Bilgilendirme Paketleri

Videolar

Ekonomik Sonuçlar

Impact of a patient blood management monitoring and feedback programme on allogeneic blood transfusions and related costs. (yeni pencere açar)

Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. (yeni pencere açar)

Hastane İrtibat Heyeti Yerel Temsilcisiyle İletişime Geçin

Tıbbi Bilgilendirme Paketleri

Videolar

Dilinizi Seçin

Paylaş